Physician profile
Terri-Danni E Pickering
NPI 1235228453
$6,675.34
in general payments reported to CMS, 2019-2025
15 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,626 · 2020: $2,707 · 2021: $82.21 · 2022: $495 · 2023: $554 · 2024: $752 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.13 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $2,397.14 | 2019-2020 | |
| Allergan, INC. | $1,373.58 | 2019-2021 | |
| Alcon Vision LLC | $987.96 | 2022-2025 | Hydrus Microstent, Rocklatan, Simbrinza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $417.47 | 2019-2020 | |
| New World Medical,INC. | $410.27 | 2024 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Abbvie INC. | $316.02 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $242.21 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Sight Sciences, INC. | $173.23 | 2019-2023 | Omni Surgical System |
| Thea Pharma INC. | $146.03 | 2023-2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $48.67 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $46.10 | 2019 | |
| Rayner Intraocular Lenses Limited | $34.21 | 2023 | Rayone Aspheric, Omidria, Rayone Emv |
| Dompe US, INC. | $32.66 | 2024 | Oxervate |
| Iridex Corporation | $27.62 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $22.17 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri-Danni Pickering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.